Coordination Pharmaceuticals
Elk Grove Village, US · Delaware corporation
Biotech
Founders & leadership
ZX
Ze-Qi XuExecutive Officer
WL
Wenbin LinDirector
JY
Jianhua YangDirector
XD
Xiaochang DaiDirector
Reported raises · per SEC filings
Form D private placements▶$18MraisedSep 2021 · 4 investors · BiotechnologyRule 506(b)
▶$18MraisedSep 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ze-Qi XuExecutive Officer
- Wenbin LinDirector
- Jianhua YangDirector
- Xiaochang DaiDirector
- Offering amount
- $22M
- Amount sold
- $18M
- Minimum investment
- $100K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.